Fundraising Fox

Cyteir Therapeutics

Cambridge, US · Founded 2012 · Delaware corporation · 3 known investors

cyteir.com ↗

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Its lead program is being studied in combination with capecitabine and gemcitabine in a Phase 1/2 clinical trial that includes patients with advanced ovarian cancer.

BiotechHealthtechin /5372945@CyteirInfo

Founders & leadership

KM
Kevin MillsExecutive Officer, Director
BM
Barry MillsDirector
RG
Ronald GoldsteinExecutive Officer
DC
Donald CorcoranExecutive Officer, Director
TR
Timothy RombergerDirector
MR
Markus RenschlerDirector

Investors · 3

Droia VenturesLeuven · $540K
Lightstone VenturesPortola Valley
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$80MraisedFeb 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • TIMOTHY ROMBERGERDirector
  • PAUL SECRISTExecutive Officer
  • ANDREW GENGOSExecutive Officer
  • SUSAN MOLINEAUXDirector
  • JOSEPH S. ZAKRZEWSKIDirector
  • KAREN HONGDirector
  • JANWILLEM NAESENSDirector
  • JEAN GEORGEDirector
  • RACQUEL BRACKENDirector
  • MARKUS RENSCHLERExecutive Officer, Director
Amount sold
$80M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.2MraisedOct 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JANWILLEM NAESENSDirector
  • JEAN GEORGEDirector
  • RACQUEL BRACKENDirector
  • MARKUS RENSCHLERExecutive Officer, Director
  • KAREN HONGDirector
  • TIMOTHY ROMBERGERExecutive Officer, Director
Amount sold
$20.2M
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.8MraisedMay 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bart Van HoolandDirector
  • Timothy RombergerExecutive Officer, Director
  • Ronald GoldsteinExecutive Officer
  • Racquel BrackenDirector
  • Markus RenschlerExecutive Officer, Director
  • Jean GeorgeDirector
Offering amount
$35M
Amount sold
$5.8M
Sales commissions
$1.4M
Placement agents
MTS Securities, LLC
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.8MraisedNov 2016 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin MillsExecutive Officer, Director
  • Barry MillsDirector
  • Ronald GoldsteinExecutive Officer
  • Donald CorcoranExecutive Officer, Director
  • Timothy RombergerDirector
  • Markus RenschlerDirector
Offering amount
$5.8M
Amount sold
$5.8M
First sale
Oct 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.